Electrocardiograph - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4403113
  • Report
  • Region: Global
  • 210 pages
  • Allied Analytics LLP
1 of 3
Electrocardiograph (ECG) devices are used to record the heart activities through electric signals and are amplified on the ECG monitor. ECG devices are essentially adopted across various medical set ups to diagnose different types of heart diseases and arrhythmias in people, thereby assisting the appropriate therapy for cardiovascular diseases (CVD) patients. The key factors that drive the market growth include increase in number of CVD patients across the globe and rise in demand for portable diagnostic as well monitoring systems. In addition, increase in old age population globally, and favorable government regulations regarding the ECG devices supplement the market growth. The global ECG market was valued at $4,516 million in 2016, and is expected to reach $6,637 million by 2023, registering a CAGR of 5.6% from 2017 to 2023.

The global ECG market is segmented on the basis of product, lead type, end user, and region. Based on product, the market is divided into resting ECG, stress ECG, and holter monitors (wired and wireless holter monitors). Based on lead type, the market is classified into single lead, 3-6 lead, and 12-lead. Based on end user, it is categorized into hospitals & clinics, home settings & ambulatory surgical centers (ASCs), and others. The holter monitor segment is growing at a fast pace, registering a CAGR of 9.1% from 2017 to 2023. In addition, ECG devices are highly incorporated in the hospitals & clinics, and has generated the highest revenue in this segment throughout the forecast period.

The market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. In the recent years, Asia-Pacific has witnessed rapid growth in the ECG market. India and China are the major contributors to the robust growth of Asia-Pacific ECG market owing to their high population density along with increase in healthcare expenditure.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the global electrocardiograph (ECG) market along with the current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
Comprehensive quantitative analysis of the industry is provided for the period of 2016–2023 to assist stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps in understanding the trends in products and lead types across the globe.
Key market players and their strategies are provided to understand the competitive outlook of the industry.

KEY MARKET SEGMENTS

By Product

Resting ECG
Stress ECG
Holter Monitors
Wired Holter Monitors
Wireless Holter Monitors

By Lead Type

Single Lead
3-6 Lead
12-Lead

By End User

Hospitals & Clinics
Home Settings & Ambulatory Surgical Centers (ASCs)
Others

By Region

North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
Spain
Switzerland
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Malaysia
New Zealand
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Egypt
Saudi Arabia
Rest of LAMEA

KEY MARKET PLAYERS

GE Healthcare (General Electric Company)
Royal Philips Healthcare (Koninklijke Philips N.V.)
Nihon Kohden Corporation
Schiller AG
Opto Circuits Limited
OSI Systems Fukuda Denshi Co Ltd.
Johnson and Johnson
Mindray Medical International Limited
Medtronic
Mortara Instrument, Inc.

The other players in the value chain include (profiles not included in the report)
Spacelabs Healthcare Inc.
Welch Allyn
Compumed Inc.
Cardionet Inc.
Bionet
Cardiac Science
Midmark Corporation
AMEDTEC Medizintechnik Aue GmbH
BPL Medical Technologies
READ MORE
Note: Product cover images may vary from those shown
2 of 3
CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATORY FRAMEWORK
3.5. TOP PLAYER POSITIONING/MARKET SHARE ANALYSIS, 2016
3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Technological advancements in ECG devices
3.6.1.2. Rise in the incidence of cardiovascular diseases across the globe
3.6.1.3. Rise in the geriatric population propels the need for cardiac monitoring devices
3.6.1.4. Favorable government regulations increasing the production of cardiac monitoring devices

3.6.2. Restraints

3.6.2.1. High cost of sophisticated ECG devices
3.6.2.2. Unfavorable reimbursement policies and market saturation

3.6.3. Opportunities

3.6.3.1. Increasing developments regarding wireless communications, and cloud computing

CHAPTER 4 ELECTROCARDIOGRAPH (ECG) MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. RESTING ELECTROCARDIOGRAPH (ECG)

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. STRESS ELECTROCARDIOGRAPH (ECG)

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. HOLTER MONITORS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Wired Holter Monitors

4.4.1.1. Market Size & Forecast

4.4.2. Wireless Holter Monitors

4.4.2.1. Market Size & Forecast

CHAPTER 5 ELECTROCARDIOGRAPH (ECG) MARKET, BY LEAD TYPE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. SINGLE LEAD ECG

5.2.1. Market size and forecast

5.3. 3-6 LEAD ECG

5.3.1. Market size and forecast

5.4. 12-LEAD ECG

5.4.1. Market size and forecast

CHAPTER 6 ELECTROCARDIOGRAPH (ECG) MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS & CLINICS

6.2.1. Market size and forecast

6.3. HOME SETTINGS & AMBULATORY SURGICAL CENTERS (ASCS)

6.3.1. Market size and forecast

6.4. OTHERS

6.4.1. Market size and forecast

CHAPTER 7 ELECTROCARDIOGRAPH (ECG) MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Mexico market size and forecast
7.2.3.3. Canada market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. UK market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. Germany market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Switzerland market size and forecast
7.3.3.7. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. India market size and forecast
7.4.3.4. Australia market size and forecast
7.4.3.5. Malaysia market size and forecast
7.4.3.6. New Zealand market size and forecast
7.4.3.7. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Egypt market size and forecast
7.5.3.2. Saudi Arabia market size and forecast
7.5.3.3. South Africa market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. GE HEALTHCARE (GENERAL ELECTRIC COMPANY)

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance
8.1.5. Key strategic moves and developments

8.2. PHILIPS HEALTHCARE (KONINKLIJKE PHILIPS N.V.)

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Key strategic moves and developments

8.3. NIHON KOHDEN CORPORATION

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Key strategic moves and developments

8.4. SCHILLER AG

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.4.5. Key strategic moves and developments

8.5. OPTO CIRCUITS LIMITED

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance
8.5.5. Key strategic moves and developments

8.6. OSI SYSTEMS FUKUDA DENSHI CO LTD.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves and developments

8.7. JOHNSON AND JOHNSON

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Key strategic moves and developments

8.8. MINDRAY MEDICAL INTERNATIONAL LIMITED

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.8.5. Key strategic moves and developments

8.9. MEDTRONIC PLC

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance
8.9.5. Key strategic moves and developments

8.10. MORTARA INSTRUMENT, INC.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Business performance
8.10.5. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll